Protara Therapeutics Inc’s filing revealed that its 10% Owner Opaleye Management Inc. unloaded Company’s shares for reported $0.22 million on Sep 12 ’24. In the deal valued at $1.71 per share,126,301 shares were sold. As a result of this transaction, Opaleye Management Inc. now holds 45,000 shares worth roughly $0.1 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Opaleye Management Inc. sold 32,600 shares, generating $55,880 in total proceeds. Upon selling the shares at $1.71, the 10% Owner now owns 51,500 shares.
Before that, Opaleye Management Inc. sold 36,492 shares. Protara Therapeutics Inc shares valued at $69,141 were divested by the 10% Owner at a price of $1.89 per share. As a result of the transaction, Opaleye Management Inc. now holds 54,600 shares, worth roughly $0.12 million.
A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who began to cover the stock in early June with a ‘”a Buy”‘ rating. Oppenheimer began covering TARA with “an Outperform” recommendation on February 17, 2021. Cowen started covering the stock on October 19, 2020. It rated TARA as “an Outperform”.
Price Performance Review of TARA
On Friday, Protara Therapeutics Inc [NASDAQ:TARA] saw its stock jump 13.00% to $2.26. Over the last five days, the stock has gained 18.32%. Protara Therapeutics Inc shares have risen nearly 20.53% since the year began. Nevertheless, the stocks have risen 78.66% over the past one year. While a 52-week high of $5.24 was reached on 04/05/24, a 52-week low of $1.04 was recorded on 10/10/24. SMA at 50 days reached $1.90, while 200 days put it at $2.66.
Levels Of Support And Resistance For TARA Stock
The 24-hour chart illustrates a support level at 2.03, which if violated will result in even more drops to 1.80. On the upside, there is a resistance level at 2.42. A further resistance level may holdings at 2.58. The Relative Strength Index (RSI) on the 14-day chart is 69.26, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.19, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 11.91%. Stochastics %K at 68.02% indicates the stock is a holding.
How much short interest is there in Protara Therapeutics Inc?
A steep rise in short interest was recorded in Protara Therapeutics Inc stocks on 2024-10-15, growing by 0.21 million shares to a total of 2.32 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-13 was 2.1 million shares. There was a rise of 9.27%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on July 29, 2020 when Guggenheim began covering the stock and recommended ‘”a Buy”‘ rating along with a $50 price target.
